BiotechTube
Home/Anbogen Therapeutics/Tsu-an Hsu, PhD
TH

Tsu-an Hsu, PhD

CEO / Co‑founder

Anbogen Therapeutics

Therapeutic Areas

Oncology

Anbogen Therapeutics Pipeline

DrugIndicationPhase
ABT-301Advanced colorectal cancerPhase 1/2

Leadership Team at Anbogen Therapeutics

JH
Joe Hsueh, MBA
President / COO
MH
Mark Horng, MD
Chief Medical Officer
View full Anbogen Therapeutics profile